--2025/Q1-- / 808.710K--
--2024/Q4-- / 36.022M--
--2024/Q361.000K / 3.894M--
Aug 7, 20242024/Q2513.000K / 4.142M--
May 8, 20242024/Q11.135M / 7.296M--
MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
EDIT Editas Medicine
- 1.310
- -0.030-2.24%
Close Dec 20 16:00 ET
- 1.306
- -0.004-0.28%
Post 20:05 ET
108.14MMarket Cap-0.52P/E (TTM)
1.380High1.280Low4.22MVolume1.330Open1.340Pre Close5.59MTurnover5.45%Turnover RatioLossP/E (Static)82.55MShares11.58052wk High0.62P/B101.29MFloat Cap1.28052wk Low--Dividend TTM77.32MShs Float99.950Historical High--Div YieldTTM7.46%Amplitude1.280Historical Low1.326Avg Price1Lot Size
Editas Medicine Key Stats
Editas Medicine Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Editas Medicine Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data
